6321 - 6330 of 8808 Results
Title
Year
-
OPENTitle: Longitudinal brain structure changes in Parkinson’s disease: A replication studyJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 19Issue #: 1Start Page: e0295069End Page: e0295069Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0295069Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0295069&type=printableCitation Count: 2
-
OPENTitle: The Sigma-2 Receptor/TMEM97, PGRMC1, and LDL Receptor Complex Are Responsible for the Cellular Uptake of Aβ42 and Its Protein AggregatesJournal Name: Molecular NeurobiologyPublisher: Springer Science and Business Media LLCVol: 57Issue #: 9Start Page: 3803End Page: 3813Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s12035-020-01988-1Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7415709Citation Count: 66
-
OPENTitle: Behavioral, neurochemical, and pathologic alterations in bacterial artificial chromosome transgenic G2019S leucine-rich repeated kinase 2 ratsJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 1Start Page: 505End Page: 518Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.07.011Best OA location URL: http://doi.org/10.1016/j.neurobiolaging.2014.07.011Citation Count: 47
-
RESTRICTEDTitle: What’s the target: understanding two decades of in silico microRNA-target predictionJournal Name: Briefings in BioinformaticsPublisher: Oxford University Press (OUP)Vol: 21Issue #: 6Start Page: 1999End Page: 2010Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/bib/bbz111Citation Count: 51
- Multitarget transcranial direct current stimulation for freezing of gait in Parkinson's disease2018OPENTitle: Multitarget transcranial direct current stimulation for freezing of gait in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 4Start Page: 642End Page: 646Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27300Best OA location URL: http://doi.org/10.1002/mds.27300Citation Count: 130
-
OPENTitle: One-Carbon Metabolism in Alzheimer’s Disease and Parkinson’s Disease Brain TissueJournal Name: NutrientsPublisher: MDPI AGVol: 14Issue #: 3Start Page: 599End Page: 599Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/nu14030599Best OA location URL: https://www.mdpi.com/2072-6643/14/3/599/pdf?version=1643524082Citation Count: 25
- Different α-synuclein prion strains cause dementia with Lewy bodies and multiple system atrophy2022OPENTitle: Different α-synuclein prion strains cause dementia with Lewy bodies and multiple system atrophyJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 119Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1073/pnas.2113489119Best OA location URL: https://escholarship.org/uc/item/3cf4v001Citation Count: 62
-
OPENTitle: Identification of Parkinson's disease subtypes with distinct brain atrophy progression and its association with clinical progressionJournal Name: PsychoradiologyPublisher: Oxford University Press (OUP)Vol: 4Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/psyrad/kkae002Best OA location URL: https://academic.oup.com/psyrad/advance-article-pdf/doi/10.1093/psyrad/kkae002/56754707/kkae002.pdfCitation Count: 6
-
OPENTitle: Functional MAOB Gene Intron 13 Polymorphism Predicts Dyskinesia in Parkinson’s DiseaseJournal Name: Parkinson's DiseasePublisher: WileyVol: 2022Issue #: 1Start Page: 1End Page: 6Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2022/5597503Best OA location URL: https://downloads.hindawi.com/journals/pd/2022/5597503.pdfCitation Count: 4
- Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis2021OPENTitle: Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia GravisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000013121Best OA location URL: https://n.neurology.org/content/neurology/98/4/e376.full.pdfCitation Count: 87